Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Ann Oncol. 2012 Apr;23(4):903-11. doi: 10.1093/annonc/mdr360. Epub 2011 Aug 12.
To compare the long-term survival outcomes between laparoscopic radical hysterectomy (LRH) and open radical hysterectomy (ORH).
We matched patients with stage IA2 to IIA cervical cancer with known risk factors for recurrence who underwent ORH and LRH.
Compared with ORH (n = 263), LRH (n = 263) did not have higher risks of recurrence [hazard ratio (HR) = 1.28; 95% confidence interval (CI) 0.62-2.64] or death (HR = 1.46; 95% CI 0.62-3.43). Even in patients with tumors >2 cm in diameter, the risks of recurrence (HR = 0.82; 95% CI 0.31-2.16) or death (HR = 1.01; 95% CI 0.35-2.95) were not higher for LRH than for ORH. The LRH and ORH group had 5-year recurrence-free survival rates of 92.8% and 94.4%, respectively (P = 0.499). LRH resulted in significantly lower estimated blood loss (379.6 versus 541.1 ml, P < 0.001) and shorter postoperative hospital stay (12.5 versus 20.3 days, P < 0.001). Intraoperative complication rates were similar in the two groups (6.8% versus 5.7%, P = 0.711), but postoperative complication rate was lower in the LRH than in the ORH group (9.2% versus 21%, P < 0.001).
LRH is an oncologically safe alternative to ORH and was associated with fewer postoperative complication and earlier recovery.
比较腹腔镜根治性子宫切除术(LRH)与开腹根治性子宫切除术(ORH)的长期生存结局。
我们将接受 ORH 和 LRH 的具有已知复发风险因素的 IA2 期至 IIA 期宫颈癌患者进行匹配。
与 ORH(n = 263)相比,LRH(n = 263)的复发风险无显著升高[风险比(HR)= 1.28;95%置信区间(CI)0.62-2.64]或死亡风险(HR = 1.46;95% CI 0.62-3.43)。即使在肿瘤直径>2 cm 的患者中,LRH 的复发风险(HR = 0.82;95% CI 0.31-2.16)或死亡风险(HR = 1.01;95% CI 0.35-2.95)也不比 ORH 高。LRH 和 ORH 组的 5 年无复发生存率分别为 92.8%和 94.4%(P = 0.499)。LRH 组的估计出血量(379.6 与 541.1 ml,P < 0.001)和术后住院时间(12.5 与 20.3 天,P < 0.001)均显著缩短。两组的术中并发症发生率相似(6.8%与 5.7%,P = 0.711),但 LRH 组的术后并发症发生率低于 ORH 组(9.2%与 21%,P < 0.001)。
LRH 是 ORH 的一种具有良好肿瘤学安全性的替代方法,并且与术后并发症发生率更低和恢复更快相关。